From: CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Probe | Average methylation level | LUAD:Normal | P | |
---|---|---|---|---|
Normal (n = 32) | LUAD (n = 456) | |||
cg22306691 | 0.1336 | 0.1122 | 0.8400 | 0.0009 |
cg26171469 | 0.1451 | 0.1425 | 0.9822 | 0.5224 |
cg14528525 | 0.0331 | 0.0315 | 0.9522 | 0.3985 |
cg05969148 | 0.1422 | 0.1275 | 0.8964 | 0.0003 |
cg06875740 | 0.1059 | 0.0898 | 0.8479 | 0.1407 |
cg27292777 | 0.0211 | 0.0209 | 0.9919 | 0.9088 |
cg08567498 | 0.0768 | 0.0750 | 0.9758 | 0.5768 |
cg09123444 | 0.0594 | 0.0568 | 0.9571 | 0.3367 |
cg24031331 | 0.0765 | 0.0800 | 1.0459 | 0.0915 |
cg14093125 | 0.0539 | 0.0508 | 0.9413 | 0.2544 |
cg26653694 | 0.0701 | 0.0666 | 0.9494 | 0.3165 |
cg11968436 | 0.0615 | 0.0579 | 0.9410 | 0.2271 |
cg00335633 | 0.0957 | 0.0947 | 0.9899 | 0.7703 |
cg18382947 | 0.1278 | 0.1253 | 0.9802 | 0.5676 |
cg23237364 | 0.0306 | 0.0332 | 1.0860 | 0.2523 |
cg01534416 | 0.2769 | 0.2327 | 0.8404 | 0.0001 |